The report also underscored the importance of maintaining muscle mass and bone density while losing weight. Since weight loss ...

People who took Zepbound had greater reductions in waist circumference and body weight, a study found.Fact checked by Nick ...

Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly.

Cigna will cap out-of-pocket costs at $200 per month for patients using the weight-loss drugs Wegovy and Zepbound through an ...

While the primary target for these medication is weight loss, it’s not the only metric by which the drugs should be evaluated ...

The percentage of overweight or obese adults prescribed GLP-1s jumped by almost 587% between 2019 and 2024, according to a ...

Experts highlight the complex mix of genetics, biology and environment in obesity. Study shows fat cells' memory affects ...

People considering weight-loss medications ... who took Zepbound compared to Wegovy, Azar said. Semaglutide (Wegovy) works by mimicking the hormone GLP-1, which the body releases after eating ...

As the Food and Drug Administration clamps down on off-brand weight loss medications, Seattle-area residents are stocking up ...

2 In key secondary endpoints, Zepbound was superior across all weight reduction targets with 64.6% of participants treated with Zepbound achieving at least 15.0% weight loss compared to 40.1% on ...

The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble as competition in the weight-loss drug market ...

Novo Nordisk’s new top executive will need to help the company close the gap with Eli Lilly, fend off emerging rivals and ...